Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearnings

Osiris Therapeutics, Inc. News

Mimedx goes after Osiris with lawsuit

The wound care provider filed the suit for allegedly falsifying and misleading consumers with clinical data.

Buy these five breakout stocks now for big gains.

These stocks look ready to break out and trade higher from current levels.

Osiris Therapeutics (OSIR) Weak On High Volume Today

Trade-Ideas LLC identified Osiris Therapeutics (OSIR) as a weak on high relative volume candidate

'Mad Money' Lightning Round: I'm Not Abandoning Rite Aid

Cramer says Osiris Therapeutics is exciting, Opko Health is a buy and you can't go wrong with PPG Industries.

Jim Cramer's 'Mad Money' Recap: Be Patient, Then Start Buying

Markets weren't as overheated today, Cramer says. You can buy stocks at great prices if you are patient.

Breaking News

Elon Musk and Tesla Set Their Sights on a Popular Industry

The electric vehicle manufacturer has a very popular industry in its sights despite often low margins.

New Trader Joe's Popcorn Just Dropped

Here's why people are freaking out about the latest Trader treat.

Tank Tips: Best Gas Saving Moves for Memorial Day

Cut costs with these Memorial Day gasoline-saving tips

Luxury-Home Builder Toll Brothers Beats Q2 Profit, Revenue Estimates

Toll Brothers earned $1.85 a share in its fiscal second quarter on 18% higher revenue.